ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

ThinkCyte-Expands

More Like This

ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones

ThinkCyte Secures $32 million in Series C Funding to Drive Global Expansion of VisionSort™

PR Newswire associated0

Cellply launches its end-to-end single cell potency characterization platform VivaCyte

PR Newswire associated0

Hamamatsu Photonics introduces CYTOQUBE, a new cell analyzer combining light-sheet optics and image analysis in a fast, user-friendly system for 3D cell screening assays

ThoughtSphere Celebrates 5 Years of Delivering AI enabled Efficiencies in Clinical Trial Operations

CytoTronics is launching its high-throughput Pixel™ Octo system (right) at the International Society for Stem Cell Research (ISSCR 2024) in Hamburg, Germany. The ISSCR conference also marks the European reveal of CytoTronics’ product portfolio, including the entry-level Pixel Primo (left), a single plate reader that brings accessibility to researchers. (Photo: Business Wire)

CytoTronics Breaks Scalability Barriers for Monitoring Live Cell Function, Reveals Pixel Octo for High-Throughput Cell Biology Discovery Applications

T-cell therapy developer, Cbio A/S Unveils 2023 Annual Report Amid Clinical Trial Preparations, Signaling Major Shift to Clinical Stage with DKK40M Financing Secured

PR Newswire associated0

bit.bio Launches ioTracker Cells Range at SLAS 2025, Adding New Visualisation Functionality to Human iPSC-derived Cell Types